Stomach Neoplasms: all 2,914 studies

Page 29 of 30. Open to participants first (880), then studies with results posted, then the rest; newest registration first within each.

• Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric CarcinomaCompletedNCT00190801Phase 2
• Study of Adjuvant Radiochemotherapy for Gastric CancerCompletedNCT00188266Phase 1/2
• S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach CancerCompletedNCT00182611Phase 3
• Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic TumorsStatus unknownNCT00178698Phase 2
• Cyclooxygenase-2-Associated Factors and Gastric Carcinogenesis Mechanisms-Clinical Association and Genomic InvestigationStatus unknownNCT00172861
• Association and Mechanism Between Cyclooxygenase-2 and Interleukin-6 in Gastric CancerStatus unknownNCT00172627
• Weekly Docetaxel/Irinotecan for Non-resectable Gastric Cancers After Cisplatin Plus 5-FU/LeucovorinCompletedNCT00166881Phase 2
• A Study of E7070 in Patients With Gastric CancerTerminatedNCT00165594Phase 1/2
• Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric CancerCompletedNCT00165464Phase 2
• Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled TrialStatus unknownNCT00165048Phase 3
• Role of Routine Nasogastric Decompression After Subtotal GastrectomyStatus unknownNCT00164918Phase 3
• Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled TrialStatus unknownNCT00164892Phase 3
• Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric CancerTerminatedNCT00155883Phase 2
• Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric CancerCompletedNCT00154778Phase 2
• Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric CancersCompletedNCT00154726Phase 2
• A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)CompletedNCT00152243Phase 3
• Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)CompletedNCT00152217Phase 3
• Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric CancerCompletedNCT00150670Phase 3
• A Trial to Evaluate Para-aortic Lymphadenectomy for Gastric CancerCompletedNCT00149279Phase 3
• Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502)TerminatedNCT00149266Phase 3
• A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal MetastasisCompletedNCT00149201Phase 3
• Randomized Trial of Adjuvant Chemotherapy With Cisplatin Followed by UFT in Serosa-positive Gastric Cancer (JCOG9206-2)CompletedNCT00147147Phase 3
• Irinotecan Versus Only Best Supportive Care for Gastric CancerCompletedNCT00144378Phase 3
• A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric CancerCompletedNCT00142350Phase 3
• Docetaxel and Capecitabine in Advanced Gastric CancerCompletedNCT00142038Phase 2
• S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach CancerStatus unknownNCT00134095Phase 2
• A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric CancerCompletedNCT00123318Phase 3
• GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110CompletedNCT00112099Phase 3
• S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach CancerCompletedNCT00103324Phase 2
• Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach CancerTerminatedNCT00103103Phase 2
• Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00089362Phase 1
• S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric CancerStatus unknownNCT00088816Phase 2
• Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After ChemotherapyCompletedNCT00087503Phase 2
• EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerTerminatedNCT00087191Not applicable
• Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT00084604Phase 2
• Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal JunctionTerminatedNCT00080002Phase 2
• Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the StomachStatus unknownNCT00075465Phase 2
• Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction AdenocarcinomaCompletedNCT00074009Phase 2
• Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric CancerCompletedNCT00072787Phase 1/2
• Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid TumorsCompletedNCT00072332Phase 1
• Irofulven in Treating Patients With Recurrent or Metastatic Gastric CancerCompletedNCT00062257Phase 2
• Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric CancerCompletedNCT00054873Phase 2
• Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal JunctionCompletedNCT00054457Phase 2
• T900607 in Treating Patients With Gastroesophageal Junction CancerCompletedNCT00054249Phase 2
• Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the EsophagusSuspendedNCT00048529Phase 2
• Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal CancerCompletedNCT00042510Phase 2
• Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the LiverCompletedNCT00041808Phase 1/2
• Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach CancerCompletedNCT00040859Phase 2
• Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing a Treatment Plan of Preoperative Chemotherapy and Radiation Therapy, Followed by SurgeryCompletedNCT00036400Phase 3
• Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction CancerCompletedNCT00032123Phase 2
• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
• Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerCompletedNCT00028496Phase 1
• Vaccine Therapy in Treating Patients With Advanced or Metastatic CancerCompletedNCT00027534Phase 1
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal CancerWithdrawnNCT00025532Phase 1
• SU006668 in Treating Patients With Advanced Solid TumorsStatus unknownNCT00024063Phase 1
• S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian CancerTerminatedNCT00023634Phase 1
• Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT00022139Phase 2
• Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorCompletedNCT00021047Phase 1/2
• Assessing Quality of Life of Patients With Stomach CancerCompletedNCT00020826
• Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal CancerCompletedNCT00020787Phase 3
• Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or StomachCompletedNCT00020761Phase 2
• Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract CancerCompletedNCT00019474Phase 2
• LMB-9 Immunotoxin in Treating Patients With Advanced Solid TumorsCompletedNCT00019435Phase 1
• Vaccine Therapy in Treating Patients With Metastatic or Recurrent CancerWithdrawnNCT00017537Phase 1
• DX-8951f in Treating Patients With Metastatic Stomach CancerCompletedNCT00017212Phase 2
• BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With ChemotherapyCompletedNCT00017056Phase 2
• BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With ChemotherapyCompletedNCT00017043Phase 2
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsCompletedNCT00014456Phase 1
• S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the EsophagusCompletedNCT00012363Phase 2
• Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal TractTerminatedNCT00012246Phase 2
• Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone SurgeryCompletedNCT00011960Phase 2
• LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal CancerStatus unknownNCT00010270Phase 1
• Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or StomachCompletedNCT00009880Phase 2
• Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach CancerCompletedNCT00006081Phase 2
• Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach CancerCompletedNCT00006038Phase 2
• Biological Therapy in Treating Patients With Advanced CancerCompletedNCT00005956Not applicable
• Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During SurgeryStatus unknownNCT00005876Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal CancerCompletedNCT00005638Phase 1
• Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or EsophagusStatus unknownNCT00005607Phase 2
• Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach CancerCompletedNCT00005599Phase 2
• Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach CancerCompletedNCT00005060Phase 3
• Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal CancerCompletedNCT00005049Phase 2
• Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel ObstructionCompletedNCT00004911Phase 1/2
• Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal ObstructionCompletedNCT00004910Phase 1/2
• Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by SurgeryCompletedNCT00004895Phase 2
• Combination Chemotherapy in Treating Patients With Advanced Stomach CancerCompletedNCT00004873Phase 2
• Biological Therapy in Treating Patients With Metastatic CancerCompletedNCT00004604Phase 1
• Liposomal Doxorubicin in Treating Patients With Advanced Stomach CancerStatus unknownNCT00004236Phase 2
• Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or StomachCompletedNCT00004235Phase 2
• S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or StomachCompletedNCT00004233Phase 2
• Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or StomachCompletedNCT00004127Phase 2
• Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach CancerCompletedNCT00004103Phase 2
• Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach CancerTerminatedNCT00004099Phase 3
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
• Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerCompletedNCT00004065Phase 1
• Chemotherapy and Radiation Therapy in Treating Patients With Stomach CancerCompletedNCT00003862Phase 2
• Irinotecan in Treating Patients With Esophageal or Stomach CancerCompletedNCT00003748Phase 2
• Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the StomachStatus unknownNCT00003617Phase 3
• Antineoplaston Therapy in Treating Patients With Stomach CancerTerminatedNCT00003524Phase 2
• Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal CancerCompletedNCT00003427Phase 1

← Stomach Neoplasms overview